Parasite

Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD
GPCR & G Protein

5-HT Receptor Adenosine Receptor Adenylate Cyclase Adrenergic Receptor Angiotensin Receptor APJ Bombesin Receptor Bradykinin Receptor cAMP Cannabinoid Receptor CaSR CCK receptor CCR CGRP Receptor CRFR CXCR Dopamine Receptor EBI2 Endothelin Receptor Formyl Peptide Receptor Free Fatty Acid Receptor G protein-coupled Bile Acid Receptor GCGR GHSR GLP Receptor Glucagon Receptor GnRH Receptor GPCR19 GPR GPR109A Guanylate Cyclase Hedgehog(Smoothened) ROCK Histamine Receptor ICMT Leukotriene Receptor LPA Receptor LPL Receptor LTR mAChR Melanocortin Receptor Melatonin Receptor mGluR Motilin Receptor MRGPR MT Receptor Neurokinin Receptor Neuropeptide Y Receptor Neurotensin Receptor NPY receptor Opioid Receptor OX Receptor Oxytocin Receptor P2Y Receptor PAFR PAR PKD PKG Prostaglandin Receptor Ras RGS Protein S1P Receptor SGLT Sigma Receptor Somatostatin Receptor TAAR TSH Receptor Urotensin Receptor Vasopressin Receptor

+MORE

Parasite

Antiparasitics are a group of drugs used to treat illnesses caused by parasites like nematodes, cestodes, trematodes, and infectious protozoa.

Parasite related products

Cat No.	Product Name	CAS No.	Product Description
V78011	Anti-inflammatory agent 40		anti~inflammatory agent 40 is a potential and orally bioactive anti-malarial and anti~inflammatory agent.
V54046	Anti-parasitic agent 3	2366983-10-8	Anti-parasitic agent 3 is an anti-parasitic agent active against drug-resistant parasites.
V76297	Anti-Trypanosoma cruzi agent-1	2854299-38-8	Anti-Trypanosoma cruzi agent-1 (Compd E5) has potent activity against Toxoplasma gondii.
V76298	Anti-Trypanosoma cruzi agent-2	2863602-85-9	Anti-Trypanosoma cruzi agent-1 (Compd 3b) is selective against NINOA trypomastigote (IC50 = 0.51 µM) and INC-5 epimastigote (IC50 = 3.06 µM) trypanosomatids and has potent anti-Toxoplasma activity.
V34844	Anti-Trypanosoma cruzi agent-4	10001-31-7	Anti-Trypanosoma cruzi agent-4 (compound 5c) is an inhibitor (blocker/antagonist) of Trypanosoma cruzi.
V79869	Anticancer agent 140		anti-cancer compound 140 (Compd 3) is a compound with potential anticancer and antiparasitic effect.
V54131	Antileishmanial agent-1	2454115-43-4	Antileishmanial agent-1 has activivty against L.
V34843	Antileishmanial agent-13	853725-86-7	Antileishmanial agent-13 is a quinoline-indigo hybrid that works as an anti-leishmanial agent against L.
V52412	Antileishmanial agent-14	1638956-72-5	Antileishmanial agent-14 is a sulfonamide analog with potential activity against Leishmania donovani promastigotes (IC50=4.1 μM).
V54070	Antileishmanial agent-15	2934738-38-0	Antileishmanial agent-15 (compound 13c) is an effective antileishmanial agent.
V34841	Antileishmanial agent-16	2934738-41-5	Antileishmanial agent-16 (compound 14c) is an anti-Leishmania agent.
V34842	Antileishmanial agent-17	2934738-40-4	Antileishmanial agent-17 is a coumarin hybrid compound with anti-Leishmanial activity (IC50 <0.78 μM).
V54115	Antileishmanial agent-18	1007567-02-3	Antileishmanial agent-18 (Compound 1e) is an antileishmanial agent.
V79480	Antileishmanial agent-19		Antileishmanial agent-19 (Compound F27) is an anti-leishmanial agent with IC50 of 3.39 μM against L.donovani promastigotes.
V54058	Antileishmanial agent-2	2863687-18-5	Antileishmanial agent-2 displays submicromolar antileishmanial activity (IC50 = 0.29 μM) and a very high selectivity index against mammalian cells.
V80377	Antileishmanial agent-20		Antileishmanial agent-20 is selective for Leishmania parasites.
V79821	Antileishmanial agent-21		Antileishmanial agent-21 (compound 4e) is an antileishmanial agent that targets the Leishmania pteridine reductase 1 (Lm-PTR1).
V54045	Antileishmanial agent-23	745033-86-7	Antileishmanial agent-23 (compound G1/9) is a potent and specific trypanothione reductase (TR) inhibitor (antagonist) with IC50 of 2.24 ± 0.52 μM.
V78023	Antileishmanial agent-24		Antileishmanial agent-24 (compound 33) is an antileishmanial drug with IC50 of 5.39 μM against amastigotes.
V79586	Antileishmanial agent-25		Antileishmanial agent-25 (compound 24) has selective antileishmanial activity against intracellular anurans, with IC50 in the range of 6.63 μM.